Journal: Communications biology
Article Title: Inhibition of sterol O-acyltransferase 1 blocks Zika virus infection in cell lines and cerebral organoids.
doi: 10.1038/s42003-024-06776-4
Figure Lengend Snippet: Fig. 9 | Inhibition of SOAT1 and DGAT2 reduces ZIKV infection of human iPSC-derived cerebral organoids. a Differentiation of hIPSCs into cerebral organoids. Two different hIPS cell lines (HMGU#1 and TISSUi006A) were used for differentiation with the StemDiff Cerebral organoid kit. b Scheme of the experimental setup. After maturation (day ~35), organoids were pre-treated with DGAT inhibitors (each 5 µM), SOAT1-specific inhibitors (ATR- 101 = 9.72 µM, K604 = 20 µM), or DMSO for 24 h, followed by inoculation with 105 TCID50 per orga- noid of ZIKV for 24 h. After removal of the inocu- lum, organoids were cultured in media supplemented with inhibitors for 3 days. Individual organoids were harvested and infection was ana- lyzed by qRT-PCR and immunoblot. c Organoids were lysed and total RNA was isolated at 3 dpi. ZIKV genome copies were analyzed by qRT-PCR. Each dot represents an individual organoid from 3 inde- pendent experiments using 2 different cell lines (mean ± SEM, n = 3, *p ≤0.05, no asterisk = not significant, Welch´s t-test). d Individual organoids from two independent experiments were lysed at 3 dpi and ZIKV E and C protein level were analyzed by immunoblot. GAPDH served as loading control. Mock-infected and pan-orthoflavivirus inhibitor (NITD008)-treated organoids were used as control. Shown is one representative immunoblot. e Band signal intensities were quantified using ImageLab. Box-and-whisker-plot shows ZIKV E and C protein levels as log2 fold change over DMSO normalized to GAPDH (center line: median, box limits: upper and lower quartiles, whiskers: 1.5 x interquartile range, points: outliers, n = 4, *p ≤0.05, **p ≤0.01, no asterisk = not significant, one-sample t-test).
Article Snippet: The following antibodies and reagents used in this study were obtained commercially: Flavivirus group antigen antibody (D1-4G2-4-15 (4G2), NBP2-52666, Novus Biologicals), Flavivirus NS1 antibody ((D/2/D6/B7), ab214337, abcam), Zika virus capsid protein antibody (GTX133317), SOAT1antibody (GTX32890) (allGeneTex),GAPDHantibody (cloneG-9, sc-365062), DGAT1 antibody (clone H-255, sc-32861) (all Santa Cruz Biotechnology), J2 dsRNA antibody (Scicons/Jena Biosciences RNT-SCI10010200), PLIN2 antibody (610102, Progen), PLIN3 antibody (HPA006427, Sigma), beta-actin antibody (clone AC-74, A2228-200UL, Sigma), FLAG antibody (F7425, Sigma), Strep-tag II antibody (ab184224, abcam), HRP-labelled secondary antibodies (Jackson ImmunoResearch), Anti-Rabbit IgGHRP conjugated (Rabbit TrueBlot) (clone eB182, 18-8816- 33, Rockland Immunochemicals), Alexa647-conjugated secondary antibody (donkey, IgG (H+ L), A-31571), BODIPY493/503 (D-3922), BODIPY 655/676 (B-3932), Hoechst 33342 (H1399), Cholesteryl BODIPY FL C12 (C3927MP) (all Invitrogen), filipin III (F4767), K-604 (SML1837), ATR-101 (SML2802), DGAT1 inhibitor (PF-04620110), DGAT2 inhibitor (PF-06424439), NITD 008 (SML2409), cholesteryl oleate (C9253), cholesterol-water soluble (~ 40mg of cholesterol per gram; balanced with methyl-β-cyclodextrin) (C4951), oleic acid-BSA complex (O3008) (all Sigma).
Techniques: Inhibition, Infection, Derivative Assay, Cell Culture, Quantitative RT-PCR, Western Blot, Isolation, Control, Whisker Assay